Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL-Reference-Cited by-同舟云学术

Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL

Published:2018-05 Issue:5 Volume:54 Page:270-279
ISSN:0300-2896
Container-title:Archivos de Bronconeumología
language:es
Short-container-title:Archivos de Bronconeumología

Author:

Calle Rubio Myriam,Rodríguez Hermosa Juan Luis,Soler-Cataluña Juan José,López-Campos José Luis,Alcazar Navarrete Bernardino,Soriano Joan B.,Rodríguez Gónzalez-Moro José Miguel,Fuentes Ferrer Manuel E.,Miravitlles Marc

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease;Celli;N Engl J Med.,2004

2. A multidimensional grading system (BODE Index) as predictor of hospitalization for COPD;Ong;Chest.,2005

3. Severe exacerbations and BODE index: Two independent risk factors for death in male COPD patients;Soler-Cataluña;Respir Med.,2009

4. Clinical audit of COPD in outpatient respiratory clinics in Spain: The EPOCONSUL study;Calle Rubio;Int J Chron Obstruct Pulmon Dis.,2017

5. Audit on the appropriateness of integrated COPD management: The ALT-BPCO project;Nardini;Multidiscip Respir Med.,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National Development in the Use of Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease: Repeated Cross-Sectional Studies from 1998 to 2018;Biomedicines;2024-02-05

2. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit;Archivos de Bronconeumología;2023-11

3. Riesgos, fenotipos y comparación de tratamiento de EPOC en atención primaria según guías GOLD y GesEPOC;Medicina de Familia. SEMERGEN;2022-11

4. Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey;International Journal of Chronic Obstructive Pulmonary Disease;2022-07

5. Testing for Vitamin D in High-Risk COPD in Outpatient Clinics in Spain: A Cross-Sectional Analysis of the VITADEPOC Study;Journal of Clinical Medicine;2022-03-01